KMT2A and leukemia: Another second generation hDot1L inhibitor, EPZ-5676 (Pinometostat), has been shown to be more potent than EPZ004777 and causes significant tumor regression in rodent subcutaneous xenograft models of MLL1-rearranged leukemia [60].